Page 1 of Clinical Trials for De Novo Kidney Transplant, 208 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
Last Updated: February 1, 2011
Condition(s): De Novo Kidney Transplant Recipients
2
Completed
Comparative Study of Modified Release (MR) Tacrolimus/MMF in de Novo Kidney Transplant Recipients
Last Updated: November 10, 2011
Condition(s): Kidney Transplantation
3
Terminated
A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients
Last Updated: February 5, 2007
Condition(s): Kidney Transplantation
4
Completed
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Last Updated: June 10, 2010
Condition(s): Kidney Transplantation; Transplantation Immunology; Host vs Graft Reaction
5
Completed
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients
Last Updated: March 28, 2011
Condition(s): Organ Transplantation, Renal Transplantation
6
Recruiting
Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
Last Updated: April 28, 2012
Condition(s): Kidney Transplantation
7
Completed
Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients
Last Updated: January 28, 2011
Condition(s): De Novo Kidney Transplantation
8
Recruiting
Everolimus in de Novo Kidney Transplant Recipients
Last Updated: April 28, 2012
Condition(s): Kidney Transplantation
9
Enrolling by invitation
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Last Updated: October 21, 2009
Condition(s): Kidney Transplantation; Renal Transplantation
10
Completed
Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
Last Updated: October 30, 2009
Condition(s): Renal Transplantation
11
Terminated
A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients
Last Updated: November 17, 2011
Condition(s): Transplant; Failure, Kidney
12
Completed
Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
Last Updated: January 28, 2011
Condition(s): Renal Transplantation
13
Terminated
MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive
Last Updated: November 1, 2011
Condition(s): De Novo Kidney Transplant
14
Recruiting
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
Last Updated: April 20, 2012
Condition(s): Kidney Transplantation
15
Completed
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
Last Updated: April 25, 2011
Condition(s): Kidney Transplantation
16
Recruiting
Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
Last Updated: May 15, 2009
Condition(s): Renal Transplantation
17
Completed
A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.
Last Updated: February 1, 2011
Condition(s): Kidney Transplantation
18
Completed
Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
Last Updated: March 30, 2011
Condition(s): Renal Transplantation
19
Active, not recruiting
Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
Last Updated: October 9, 2008
Condition(s): End Stage Renal Disease; Kidney Transplantation
20
Completed
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
Last Updated: November 1, 2011
Condition(s): Renal Transplantation

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=De+Novo+Kidney+Transplant

Page 1 of Clinical Trials for De Novo Kidney Transplant, 208 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About